Daehan Nupharm Co.,Ltd. (KOSDAQ:054670)

Daehan Nupharm Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	May 7, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	91,229	92,212	96,422	127,019	119,861	152,985
Market Cap Growth	-3.56%	-4.37%	-24.09%	5.97%	-21.65%	-13.49%
Enterprise Value	157,183	155,749	114,707	125,867	131,114	172,368
Last Close Price	6500.00	6570.00	6766.22	8786.32	8199.26	10348.04
PE Ratio	5.98	6.04	6.23	10.13	4.93	9.75
PS Ratio	0.45	0.46	0.48	0.62	0.61	0.92
PB Ratio	0.65	0.66	0.77	1.16	1.16	1.86
P/TBV Ratio	0.66	0.67	0.78	1.17	1.17	1.87
P/FCF Ratio	-	-	-	44.89	11.08	25.68
P/OCF Ratio	18.03	18.22	5.09	10.11	8.41	9.23
EV/Sales Ratio	0.78	0.77	0.57	0.62	0.66	1.03
EV/EBITDA Ratio	9.97	9.72	5.04	5.63	4.21	5.80
EV/EBIT Ratio	13.70	13.28	6.15	6.67	4.69	6.53
EV/FCF Ratio	-3.48	-	-	44.48	12.12	28.93
Debt / Equity Ratio	0.71	0.71	0.47	0.34	0.36	0.45
Debt / EBITDA Ratio	6.17	6.17	2.61	1.64	1.18	1.24
Debt / FCF Ratio	-	-	-	12.93	3.39	6.20
Net Debt / Equity Ratio	0.47	0.47	0.18	0.12	0.07	0.18
Net Debt / EBITDA Ratio	4.12	4.12	0.96	0.57	0.23	0.49
Net Debt / FCF Ratio	-1.46	-1.46	-1.56	4.53	0.67	2.45
Asset Turnover	0.82	0.82	1.01	1.18	1.21	1.15
Inventory Turnover	2.84	2.84	3.04	3.54	4.30	4.83
Quick Ratio	0.97	0.97	1.06	1.01	1.11	1.16
Current Ratio	1.55	1.55	1.61	1.60	1.75	1.69
Return on Equity (ROE)	11.50%	11.50%	13.18%	11.81%	26.23%	22.15%
Return on Assets (ROA)	2.98%	2.98%	5.86%	6.81%	10.68%	11.36%
Return on Invested Capital (ROIC)	5.88%	6.64%	11.66%	9.84%	19.00%	20.15%
Return on Capital Employed (ROCE)	5.90%	5.90%	12.50%	16.40%	25.20%	23.40%
Earnings Yield	16.72%	16.55%	16.04%	9.87%	20.29%	10.26%
FCF Yield	-49.52%	-48.99%	-14.61%	2.23%	9.03%	3.90%
Payout Ratio	9.20%	9.20%	9.07%	11.19%	4.62%	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.